Charitable Grants Fill the Funding Void

Foundation funds have taken up some of the slack left by waning federal budgets, but such grants don’t often cover indirect research costs.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, US DEPARTMENT OF THE TREASURYUS life-science researchers of all stripes continue to feel the funding pinch caused by October’s government shutdown and the budget-shrinking sequester. But as federal research grant programs have dried up, some researchers have sought other sources of grant money, including charitable organizations. In the 2012 fiscal year, universities, foundations, independent research institutes, and voluntary health organizations contributed to a $1.42 billion increase in non-governmental research funding over 2011, according to a new report from Research!America on the shifting science funding landscape. “As federal funding becomes more competitive, applications to foundation sources continue to increase, stiffening the competition in the already challenging nongovernment environment,” the report, released yesterday (December 17), stated. “Some philanthropic funders have been in a position to increase support in recent years, but these grants are often more competitive than federally supported grants, and many are not open to competition.”

And competition is just one of the drawbacks for researchers turning toward foundation grants to keep their research programs funded. According to Nature, many charitable grants, even sizeable ones, fail to cover indirect costs, such as computational support, lab techs, and building fees. “People have been discouraged from applying for grants because the department has to cover the shortfall,” Lita Nelsen, director of the technology-licensing office at the Massachusetts Institute of Technology, told Nature. “We’re at the edge here of turning down money.”

Most philanthropic organizations, such as the Bill & Melinda Gates Foundation, only cover 10 percent of indirect costs, or overhead, while federal grants cover 100 percent. This leaves awardees scrambling to find a way to pay for overhead on the projects they ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies